0

Journal Articles

in Obesity Treatment
 1-15 of 15 Articles
Original Investigation |  January 28, 2013
Translating the Diabetes Prevention Program Lifestyle Intervention for Weight Loss Into Primary Care:  A Randomized Trial
Jun Ma, MD, PhD; Veronica Yank, MD; Lan Xiao, PhD; et al.
JAMA Intern Med. 2013;173(2):113-121. doi:10.1001/2013.jamainternmed.987.
INCLUDES: , Supplemental Content
Original Investigation |  January 28, 2013
Integrating Technology Into Standard Weight Loss Treatment:  A Randomized Controlled Trial
Bonnie Spring, PhD; Jennifer M. Duncan, PsyD; E. Amy Janke, PhD; et al.
JAMA Intern Med. 2013;173(2):105-111. doi:10.1001/jamainternmed.2013.1221.
Invited Commentary |  January 28, 2013
The Future of Obesity Treatment:  Comment on “Integrating Technology Into Standard Weight Loss Treatment: A Randomized Controlled Trial”
Goutham Rao, MD; Katherine Kirley, MD
JAMA Intern Med. 2013;173(2):111-112. doi:10.1001/jamainternmed.2013.1232.
Research Letters |  June 14, 2010 FREE
Fatal Malnutrition 6 Years After Gastric Bypass Surgery
Alisha N. Wade, MBBS, DPhil; Jennifer M. Dolan, MS, RD, CNSC; Carolyn L. Cambor, MD; et al.
Arch Intern Med. 2010;170(11):993-995. doi:10.1001/archinternmed.2010.164.
Editor's Correspondence |  February 08, 2010
The Evidence Chasm
Roy C. Ziegelstein, MD; Cynthia S. Rand, PhD
Arch Intern Med. 2010;170(3):306. doi:10.1001/archinternmed.2009.540.
Original Investigation |  January 25, 2010 FREE
A Randomized Trial of a Low-Carbohydrate Diet vs Orlistat Plus a Low-Fat Diet for Weight Loss
William S. Yancy, MD, MHS; Eric C. Westman, MD, MHS; Jennifer R. McDuffie, PhD, RD, MPH; et al.
Arch Intern Med. 2010;170(2):136-145. doi:10.1001/archinternmed.2009.492.
Original Investigation |  May 10, 2004 FREE
The Efficacy and Safety of Sibutramine for Weight Loss:  A Systematic Review
David E. Arterburn, MD, MPH; Paul K. Crane, MD, MPH; David L. Veenstra, PharmD, PhD
Arch Intern Med. 2004;164(9):994. doi:10.1001/archinte.164.9.994.
Original Investigation |  May 12, 2003 FREE
National Trends in Antiobesity Medication Use
Randall S. Stafford, MD, PhD; David C. Radley, BA
Arch Intern Med. 2003;163(9):1046-1050. doi:10.1001/archinte.163.9.1046.
Original Investigation |  November 25, 2002 FREE
The Effect of Orlistat-Induced Weight Loss, Without Concomitant Hypocaloric Diet, on Cardiovascular Risk Factors and Insulin Sensitivity in Young Obese Chinese Subjects With or Without Type 2 Diabetes
Peter C. Y. Tong, MBBS, PHD, MRCP; Zoe S. K. Lee, PhD; Man-Mei Sea, MPhil; et al.
Arch Intern Med. 2002;162(21):2428-2435. doi:10.1001/archinte.162.21.2428.
Editor's Correspondence |  May 13, 2002
Are There Benefits From Long-term Pharmacotherapy of Obesity?
Patrick Kearns, MD
Arch Intern Med. 2002;162(9):1070. doi:.
Review Article |  August 13, 2001 FREE
Long-term Pharmacotherapy of Obesity 2000:  A Review of Efficacy and Safety
Gary Glazer, MD
Arch Intern Med. 2001;161(15):1814-1824. doi:10.1001/archinte.161.15.1814.
Original Investigation |  January 22, 2001 FREE
Benefits of Lifestyle Modification in the Pharmacologic Treatment of Obesity:  A Randomized Trial
Thomas A. Wadden, PhD; Robert I. Berkowitz, MD; David B. Sarwer, PhD; et al.
Arch Intern Med. 2001;161(2):218-227. doi:10.1001/archinte.161.2.218.
Original Investigation |  July 24, 2000 FREE
Efficacy and Safety of Sibutramine in Obese White and African American Patients With Hypertension:  A 1-Year, Double-blind, Placebo-Controlled, Multicenter Trial
F. Gilbert McMahon, MD, MS, FAACP; Ken Fujioka, MD; Bramah N. Singh, MD, PhD; et al.
Arch Intern Med. 2000;160(14):2185-2191. doi:10.1001/archinte.160.14.2185.
Original Investigation |  May 08, 2000 FREE
Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese Adults
Steven B. Heymsfield, MD; Karen R. Segal, PhD; Jonathan Hauptman, MD; et al.
Arch Intern Med. 2000;160(9):1321-1326. doi:10.1001/archinte.160.9.1321.
Original Investigation |  June 08, 1998 FREE
Effective Lipid Modification by Partial Ileal Bypass Reduced Long-term Coronary Heart Disease Mortality and Morbidity: Five-Year Posttrial Follow-up Report From the POSCH
Henry Buchwald, MD, PhD; Richard L. Varco, MD, PhD; James R. Boen, PhD; et al.
Arch Intern Med. 1998;158(11):1253-1261. doi:10.1001/archinte.158.11.1253.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  April 01, 2013
Increased Admission for Alcohol Dependence After Gastric Bypass Surgery Compared With Restrictive Bariatric Surgery
Magdalena Plecka Östlund, MD, PhD; Olof Backman, MD; Richard Marsk, MD, PhD; et al.
JAMA Surgery
Original Article  |  December 17, 2012
Portomesenteric Thrombosis Following Laparoscopic Bariatric Surgery:  Incidence, Patterns of Clinical Presentation, and Etiology in a Bariatric Patient Population
David Goitein, MD; Ibrahim Matter, MD; Asnat Raziel, MD; et al.
JAMA Surgery
From the JAMA Network  |  April 01, 2013
Why Isn't Bariatric Surgery for Adolescents Catching On?
Kimberley Eden Steele, MD
JAMA Surgery
Original Article  |  Mar 2013
Expectations for Weight Loss and Willingness to Accept Risk Among Patients Seeking Weight Loss Surgery
Christina C. Wee, MD, MPH; Mary Beth Hamel, MD, MPH; Caroline M. Apovian, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems